The Nines board includes Accel partner Steve Loughlin and 8VC founding partner Joe Lonsdale.
Accel partner Steve Loughlin: “The power of AI comes from applying it to defined problems. Nines combines exceptional AI and health care expertise. The Nines platform presents a true patient-first approach with the goal of improving outcomes and offering up greater efficiencies and reduced time to diagnosis.”
8VC founding partner Joe Lonsdale: “We invested in Nines because of David and Alex. They have built the strongest AI and technical team we've seen in the space and combined it with deeply relevant -- and impressive -- medical experience.”
Ad Statistics
Times Displayed: 72465
Times Visited: 2387 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The Nines team will be at the 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Dec. 1-7 at McCormick Place in Chicago.
About Nines
Nines provides a better approach to teleradiology, improving patient care with an amazing team of clinical experts, engineers, and data scientists. Nines is backed by Accel and 8VC and is based in Palo Alto, Calif. For more information, including career opportunities, visit https://www.ninesradiology.com/.
The Nines Advisory Board
Dr. Burton Drayer, Chair of Radiology for the Mount Sinai Health System and Professor of Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai
Dr. David Mendelson, Vice Chair, Radiology, IT, for the Mount Sinai Health System and Professor of Radiology at the Icahn School of Medicine at Mount Sinai
Dr. Sam Gambhir, Chair, Department of Radiology
Dr. Curt Langlotz, Professor of Radiology & Informatics
Dr. Matthew Lungren, Assistant Professor, Radiology
Dr. Thomas Montine, Department Chair, Department of Pathology
Dr. Max Wintermark, Professor of Radiology (Neuroimaging and Neurointervention)
About Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP) is responsible for driving the real-world application and commercialization of Mount Sinai discoveries and inventions, and the development of research partnerships with industry. Our aim is to translate discoveries and inventions into health care products and services that benefit patients and society. MSIP is accountable for the full spectrum of commercialization activities required to bring Mount Sinai inventions to life. These activities include evaluating, patenting, marketing and licensing new technologies building research, collaborations and partnerships with commercial and nonprofit entities, material transfer and confidentiality, coaching innovators to advance commercially-relevant translational discoveries, and actively fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities.
Back to HCB News
